Vés al contingut

Cercador de Publicacions

La producció científica dels nostres investigadors i investigadores és molt elevada. L'any 2022 es van publicar 1.629 articles a revistes científiques amb un factor d'impacte global que va superar els 15.000 punts.

Effects of an incremental maximal endurance exercise stress-induced cortisol on cognitive performance

PMID: NOPMID0052
Revista: JOURNAL OF HUMAN SPORT AND EXERCISE
Any: 2019
Referència: Journal of Human Sport and Exercise, 14(3), 632-644. doi:https://doi.org/10.14198/jhse.2019.143.13
Factor d'impacte: 0
Tipus de publicació: Article en revista nacional
Autors: , , Marco Ahulló, Adria, , et al.
DOI: 10.14198/jhse.2019.143.13

Effects of an incremental maximal endurance exercise stress-induced cortisol on cognitive performance

PMID: NOPMID0052
Revista: JOURNAL OF HUMAN SPORT AND EXERCISE
Any: 2019
Referència: Journal of Human Sport and Exercise, 14(3), 632-644. doi:https://doi.org/10.14198/jhse.2019.143.13
Factor d'impacte:
Tipus de publicació: Article en revista nacional
Autors: ; ; ; ; Marco Ahulló, Adria et al.
DOI: 10.14198/jhse.2019.143.13

Effects of autologous adipose-derived regenerative stem cells administered at the time of anterior cruciate ligament reconstruction on knee function and graft healing.

PMID: 31470759
Revista: Journal of Orthopaedic Surgery
Any: 2019
Referència: J Orthop Surg (Hong Kong). 2019 Sep-Dec;27(3):2309499019867580. doi: 10.1177/2309499019867580.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Alentorn-Geli, Eduard; Alvarez-Diaz, Pedro; Barastegui, David; Catala, Jordi; Cugat, Ramon; Cusco, Xavier; Garcia-Balletbo, Montserrat; Laiz, Patricia; Martinez-De la Torre, Adrian; Navarro, Jordi et al.
DOI: 10.1177/2309499019867580

Effects of long-term cysteamine treatment in patients with cystinosis.

PMID: 29260317
Revista: PEDIATRIC NEPHROLOGY
Any: 2019
Referència: Pediatr Nephrol. 2019 Apr;34(4):571-578. doi: 10.1007/s00467-017-3856-4. Epub 2017 Dec 19.
Factor d'impacte: 2.816
Tipus de publicació: Revisió en revista nacional
Autors: Ariceta, Gema, Giordano, Vincenzo, Santos, Fernando et al.
DOI: 10.1007/s00467-017-3856-4

Effects of long-term cysteamine treatment in patients with cystinosis.

PMID: 29260317
Revista: PEDIATRIC NEPHROLOGY
Any: 2019
Referència: Pediatr Nephrol. 2019 Apr;34(4):571-578. doi: 10.1007/s00467-017-3856-4. Epub 2017 Dec 19.
Factor d'impacte:
Tipus de publicació: Revisió en revista nacional
Autors: Ariceta, Gema; Giordano, Vincenzo; Santos, Fernando et al.
DOI: 10.1007/s00467-017-3856-4

Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy. Results of the EUROCONDOR Clinical Trial.

PMID: 30389750
Revista: DIABETES
Any: 2019
Referència: Diabetes. 2019 Feb;68(2):457-463. doi: 10.2337/db18-0682. Epub 2018 Nov 2.
Factor d'impacte: 7.199
Tipus de publicació: Article en revista internacional
Autors: Simo, Rafael, Hernandez, Cristina, Porta, Massimo, Bandello, Francesco, Grauslund, Jakob, Harding, Simon P, Aldington, Stephen J, Egan, Catherine, Frydkjaer-Olsen, Ulrik, Garcia-Arumi, Jose et al.
DOI: 10.2337/db18-0682

Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy. Results of the EUROCONDOR Clinical Trial.

PMID: 30389750
Revista: DIABETES
Any: 2019
Referència: Diabetes. 2019 Feb;68(2):457-463. doi: 10.2337/db18-0682. Epub 2018 Nov 2.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Aldington, Stephen J; Bandello, Francesco; Costa, Miguel Angelo; Cunha-Vaz, Jose; Egan, Catherine; Frydkjaer-Olsen, Ulrik; Garcia-Arumi, Jose; Gibson, Jonathan; Grauslund, Jakob; Harding, Simon P et al.
DOI: 10.2337/db18-0682

Efficacy and Safety of a Two-Drug Direct-Acting Antiviral Agent Regimen Ruzasvir 180 mg and Uprifosbuvir 450 mg for 12 Weeks in Adults with Chronic Hepatitis C Virus Genotype 1, 2, 3, 4, 5, or 6.

PMID: 31108015
Revista: JOURNAL OF VIRAL HEPATITIS
Any: 2019
Referència: J Viral Hepat. 2019 Sep;26(9):1127-1138. doi: 10.1111/jvh.13132. Epub 2019 Jul 11.
Factor d'impacte: 4.016
Tipus de publicació: Article en revista internacional
Autors: Foster, Graham R, Rabinovitz, Mordechai, Burnevich, Eduard, Katchman, Helena, Tomasiewicz, Krzysztof, Lahser, Fred, Jackson, Beth, Shaughnessy, Melissa, Klopfer, Stephanie, Yeh, Wendy W et al.
DOI: 10.1111/jvh.13132

Efficacy and Safety of a Two-Drug Direct-Acting Antiviral Agent Regimen Ruzasvir 180 mg and Uprifosbuvir 450 mg for 12 Weeks in Adults with Chronic Hepatitis C Virus Genotype 1, 2, 3, 4, 5, or 6.

PMID: 31108015
Revista: JOURNAL OF VIRAL HEPATITIS
Any: 2019
Referència: J Viral Hepat. 2019 Sep;26(9):1127-1138. doi: 10.1111/jvh.13132. Epub 2019 Jul 11.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Agarwal, Kaushik; Ari, Ziv Ben; Barr, Eliav; Bernhardi, David C; Borgia, Sergio; Brown, Ashley; Burnevich, Eduard; Burnevich, Eduard Z; Buti, Maria; Cohen, Michal et al.
DOI: 10.1111/jvh.13132

Efficacy and safety of Gelsectan for diarrhoea-predominant irritable bowel syndrome: A randomised, crossover clinical trial.

PMID: 31662866
Revista: United European Gastroenterology Journal
Any: 2019
Referència: United European Gastroenterol J. 2019 Oct;7(8):1093-1101. doi: 10.1177/2050640619862721. Epub 2019 Jul 3.
Factor d'impacte: 3.453
Tipus de publicació: Article en revista internacional
Autors: Trifan, Anca, Burta, Ovidiu, Tiuca, Nicoleta, Petrisor, Diana Corina, Lenghel, Augustin, Santos, Javier et al.
DOI: 10.1177/2050640619862721

Efficacy and safety of Gelsectan for diarrhoea-predominant irritable bowel syndrome: A randomised, crossover clinical trial.

PMID: 31662866
Revista: United European Gastroenterology Journal
Any: 2019
Referència: United European Gastroenterol J. 2019 Oct;7(8):1093-1101. doi: 10.1177/2050640619862721. Epub 2019 Jul 3.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Burta, Ovidiu; Lenghel, Augustin; Petrisor, Diana Corina; Santos, Javier; Tiuca, Nicoleta; Trifan, Anca et al.
DOI: 10.1177/2050640619862721

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.

PMID: 30672091
Revista: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
Any: 2019
Referència: J Peripher Nerv Syst. 2019 Mar;24(1):48-55. doi: 10.1111/jns.12302. Epub 2019 Feb 15.
Factor d'impacte: 2.441
Tipus de publicació: Article en revista internacional
Autors: Schmidt, J, Merkies, Ingemar S J, van Schaik, Ivo N, D'Amour, C, Kunc, P, Valis, M, Sussova, J, Kalous, T, Talab, R, Bednar, M et al.
DOI: 10.1111/jns.12302

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.

PMID: 30672091
Revista: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
Any: 2019
Referència: J Peripher Nerv Syst. 2019 Mar;24(1):48-55. doi: 10.1111/jns.12302. Epub 2019 Feb 15.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Ajroud-Driss, S; Akutsu, T; Algom, A; Allen, J; Antonia, M; Antonini, G; Attarian, S; Aufauvre, D; Auranen, M; Baba, M et al.
DOI: 10.1111/jns.12302

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.

PMID: 30739747
Revista: LANCET
Any: 2019
Referència: Lancet. 2019 Mar 9;393(10175):1021-1032. doi: 10.1016/S0140-6736(19)30195-3. Epub 2019 Feb 7.
Factor d'impacte: 59.102
Tipus de publicació: Article en revista internacional
Autors: Dodd, Robert, Ali, Hasan, Carhuapoma, J Ricardo, Kase, Carlos S, Lees, Kennedy R, Dawson, Jesse, Wilson, Alastair, Betz, Joshua F, Sugar, Elizabeth A, Hao, Yi et al.
DOI: 10.1016/S0140-6736(19)30195-3

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.

PMID: 30739747
Revista: LANCET
Any: 2019
Referència: Lancet. 2019 Mar 9;393(10175):1021-1032. doi: 10.1016/S0140-6736(19)30195-3. Epub 2019 Feb 7.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Abdul-Rahim, Azmil; Abou-Hamden, Amal; Abraham, Michael; Ahmed, Azam; Alba, Carlos Alarcon; Aldrich, E Francois; Ali, Hasan; Altschul, David; Amin-Hanjani, Sepideh; Anderson, Craig S et al.
DOI: 10.1016/S0140-6736(19)30195-3

Efficacy and safety of omalizumab (Xolair(R)) for cholinergic urticaria in patients unresponsive to a double dose of antihistamines: a randomized mixed double-blind and open-label placebo-controlled clinical trial.

PMID: 30654196
Revista: Journal of Allergy and Clinical Immunology-In Practice
Any: 2019
Referència: J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1599-1609.e1. doi: 10.1016/j.jaip.2018.12.025. Epub 2019 Jan 15.
Factor d'impacte: 7.55
Tipus de publicació: Article en revista internacional
Autors: Nunez-Cordoba, Jorge M, Baeza, Maria Luisa, Echechipia, Susana, Gaig, Pere, Garcia, Blanca Esther, Labrador-Horrillo, Moises, Sala-Cunill, Ana, Bresco, Marina Sabate, Beristain, Ana, Quinones, Dolores et al.
DOI: 10.1016/j.jaip.2018.12.025

Efficacy and safety of omalizumab (Xolair(R)) for cholinergic urticaria in patients unresponsive to a double dose of antihistamines: a randomized mixed double-blind and open-label placebo-controlled clinical trial.

PMID: 30654196
Revista: Journal of Allergy and Clinical Immunology-In Practice
Any: 2019
Referència: J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1599-1609.e1. doi: 10.1016/j.jaip.2018.12.025. Epub 2019 Jan 15.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Azofra, Julian; Baeza, Maria Luisa; Beristain, Ana; Bresco, Marina Sabate; Donado, Carmen Diaz; Echechipia, Susana; Ferrer, Marta; Gaig, Pere; Garcia, Blanca Esther; Gastaminza, Gabriel et al.
DOI: 10.1016/j.jaip.2018.12.025

Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study.

PMID: 30043658
Revista: Multiple Sclerosis Journal
Any: 2019
Referència: Mult Scler. 2019 Aug;25(9):1255-1262. doi: 10.1177/1352458518789884. Epub 2018 Jul 25.
Factor d'impacte: 5.649
Tipus de publicació: Article en revista internacional
Autors: Cohen, Jeffrey A, Comi, Giancarlo, Arnold, Douglas L, Bar-Or, Amit, Selmaj, Krzysztof W, Steinman, Lawrence, Havrdova, Eva K, Cree, Bruce Ac, Montalban, Xavier, Hartung, Hans-Peter et al.
DOI: 10.1177/1352458518789884

Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study.

PMID: 30043658
Revista: Multiple Sclerosis Journal
Any: 2019
Referència: Mult Scler. 2019 Aug;25(9):1255-1262. doi: 10.1177/1352458518789884. Epub 2018 Jul 25.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Arnold, Douglas L; Bar-Or, Amit; Cohen, Jeffrey A; Comi, Giancarlo; Cree, Bruce Ac; Frohna, Paul; Hartung, Hans-Peter; Havrdova, Eva K; Huang, Vivian; Kappos, Ludwig et al.
DOI: 10.1177/1352458518789884

Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial.

PMID: 31420397
Revista: BMJ Open
Any: 2019
Referència: BMJ Open. 2019 Aug 15;9(8):e030648. doi: 10.1136/bmjopen-2019-030648.
Factor d'impacte: 2.376
Tipus de publicació: Article en revista internacional
Autors: Vaquero, Jose Manuel, Paez-Vega, Aurora, Cantisan, Sara, Lobo-Acosta, Maria Angeles, Perez, Ana Belen, Alonso-Moralejo, Rodrigo, Iturbe, David, Monforte, Victor, Otero-Gonzalez, Isabel, Pastor, Amparo et al.
DOI: 10.1136/bmjopen-2019-030648

Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial.

PMID: 31420397
Revista: BMJ Open
Any: 2019
Referència: BMJ Open. 2019 Aug 15;9(8):e030648. doi: 10.1136/bmjopen-2019-030648.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Alonso-Moralejo, Rodrigo; Cantisan, Sara; Iturbe, David; Lobo-Acosta, Maria Angeles; Luque-Pineda, Antonio; Monforte, Victor; Otero-Gonzalez, Isabel; Paez-Vega, Aurora; Pastor, Amparo; Perez, Ana Belen et al.
DOI: 10.1136/bmjopen-2019-030648

Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1).

PMID: 31433997
Revista: PULMONARY PHARMACOLOGY & THERAPEUTICS
Any: 2019
Referència: Pulm Pharmacol Ther. 2019 Oct;58:101834. doi: 10.1016/j.pupt.2019.101834. Epub 2019 Aug 18.
Factor d'impacte: 2.669
Tipus de publicació: Article en revista internacional
Autors: Loebinger, Michael R, Polverino, Eva, Blasi, Francesco, Elborn, Stuart J, Chalmers, James D, Tiddens, Harm Awm, Goossens, Herman, Tunney, Michael, Zhou, Wenchun, Angyalosi, Gerhild et al.
DOI: 10.1016/j.pupt.2019.101834

Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1).

PMID: 31433997
Revista: PULMONARY PHARMACOLOGY & THERAPEUTICS
Any: 2019
Referència: Pulm Pharmacol Ther. 2019 Oct;58:101834. doi: 10.1016/j.pupt.2019.101834. Epub 2019 Aug 18.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Angyalosi, Gerhild; Blasi, Francesco; Chalmers, James D; Elborn, Stuart J; Goossens, Herman; Haworth, Charles S; Hill, Adam T; Loebinger, Michael R; Polverino, Eva; Tiddens, Harm Awm et al.
DOI: 10.1016/j.pupt.2019.101834

Efficacy and toxicity of sorafenib in the treatment of advanced medullary thyroid carcinoma: A systematic review and meta-analysis.

PMID: 31162772
Revista: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Any: 2019
Referència: Head Neck. 2019 Aug;41(8):2823-2829. doi: 10.1002/hed.25832. Epub 2019 Jun 4.
Factor d'impacte: 2.442
Tipus de publicació: Revisió en revista internacional
Autors: Vuong, Huy Gia, Ho, An Thi Nhat, Tran, Thao T K, Capdevila, Jaume, Benekli, Mustafa, Nakazawa, Tadao, Katoh, Ryohei, Kondo, Tetsuo et al.
DOI: 10.1002/hed.25832